{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:58:09Z","timestamp":1793663889781,"version":"4.5.1"},"reference-count":192,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03769-9","type":"journal-article","created":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T02:16:19Z","timestamp":1767492979000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Molecular and multimodal biomarkers in Moyamoya disease: from pathogenic mechanisms to clinical translation"],"prefix":"10.1186","volume":"31","author":[{"given":"Jinghong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqiang","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunchu","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,3]]},"reference":[{"issue":"8","key":"3769_CR1","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S1474-4422(22)00165-X","volume":"21","author":"M Ihara","year":"2022","unstructured":"Ihara M, Yamamoto Y, Hattori Y, Liu W, Kobayashi H, Ishiyama H, et al. Moyamoya disease: diagnosis and interventions. Lancet Neurol. 2022;21(8):747\u201358.","journal-title":"Lancet Neurol"},{"issue":"6","key":"3769_CR2","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1212\/01.wnl.0000176066.33797.82","volume":"65","author":"K Uchino","year":"2005","unstructured":"Uchino K, Johnston SC, Becker KJ, Tirschwell DL. Moyamoya disease in Washington State and California. Neurology. 2005;65(6):956\u20138.","journal-title":"Neurology"},{"issue":"1","key":"3769_CR3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/jhg.2010.132","volume":"56","author":"F Kamada","year":"2011","unstructured":"Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, Kikuchi A, et al. A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. J Hum Genet. 2011;56(1):34\u201340.","journal-title":"J Hum Genet"},{"issue":"7","key":"3769_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022542","volume":"6","author":"W Liu","year":"2011","unstructured":"Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T, et al. Identification of RNF213 as a susceptibility gene for Moyamoya disease and its possible role in vascular development. PLoS ONE. 2011;6(7):e22542.","journal-title":"PLoS ONE"},{"issue":"21","key":"3769_CR5","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1097\/CM9.0000000000002985","volume":"137","author":"J Fang","year":"2024","unstructured":"Fang J, Yang X, Ni J. RNF213 in Moyamoya disease: genotype-phenotype association and the underlying mechanism. Chin Med J. 2024;137(21):2552\u201360.","journal-title":"Chin Med J"},{"key":"3769_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-025-05103-0","author":"J Shen","year":"2025","unstructured":"Shen J, Wang Y, Qin Y, Chen G, Xu J, Li Y, et al. RNF213 knockdown and inflammation promote angiogenesis and phenotype switching by JAK2\/STAT3 pathway in Moyamoya disease. Mol Neurobiol. 2025. https:\/\/doi.org\/10.1007\/s12035-025-05103-0.","journal-title":"Mol Neurobiol"},{"issue":"10","key":"3769_CR7","doi-asserted-by":"publisher","first-page":"e465","DOI":"10.1161\/STR.0000000000000443","volume":"54","author":"NR Gonzalez","year":"2023","unstructured":"Gonzalez NR, Amin-Hanjani S, Bang OY, Coffey C, Du R, Fierstra J, et al. Adult Moyamoya disease and syndrome: current perspectives and future directions: a scientific statement from the American Heart Association\/American Stroke Association. Stroke. 2023;54(10):e465\u201379.","journal-title":"Stroke"},{"issue":"2","key":"3769_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s12199-015-0498-7","volume":"21","author":"A Koizumi","year":"2016","unstructured":"Koizumi A, Kobayashi H, Hitomi T, Harada KH, Habu T, Youssefian S. A new horizon of Moyamoya disease and associated health risks explored through RNF213. Environ Health Prev Med. 2016;21(2):55\u201370.","journal-title":"Environ Health Prev Med"},{"key":"3769_CR9","first-page":"49","volume":"8","author":"S Guey","year":"2015","unstructured":"Guey S, Tournier-Lasserve E, Herv\u00e9 D, Kossorotoff M. Moyamoya disease and syndromes: from genetics to clinical management. Appl Clin Genet. 2015;8:49\u201368.","journal-title":"Appl Clin Genet"},{"key":"3769_CR10","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.brainres.2014.11.014","volume":"1594","author":"A Ito","year":"2015","unstructured":"Ito A, Fujimura M, Niizuma K, Kanoke A, Sakata H, Morita-Fujimura Y, et al. Enhanced post-ischemic angiogenesis in mice lacking RNF213; a susceptibility gene for Moyamoya disease. Brain Res. 2015;1594:310\u201320.","journal-title":"Brain Res"},{"issue":"1","key":"3769_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10143-007-0102-8","volume":"31","author":"S Sakamoto","year":"2008","unstructured":"Sakamoto S, Kiura Y, Yamasaki F, Shibukawa M, Ohba S, Shrestha P, et al. Expression of vascular endothelial growth factor in dura mater of patients with Moyamoya disease. Neurosurg Rev. 2008;31(1):77\u201381.","journal-title":"Neurosurg Rev"},{"issue":"10","key":"3769_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047158","volume":"7","author":"YS Park","year":"2012","unstructured":"Park YS, Jeon YJ, Kim HS, Chae KY, Oh SH, Han IB, et al. The role of VEGF and KDR polymorphisms in Moyamoya disease and collateral revascularization. PLoS ONE. 2012;7(10):e47158.","journal-title":"PLoS ONE"},{"issue":"1","key":"3769_CR13","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3892\/etm.2014.1713","volume":"8","author":"J He","year":"2014","unstructured":"He J, Wang R, Zhang D, Zhang Y, Zhang Q, Zhao J. Expression of circulating vascular endothelial growth factor-antagonizing cytokines and vascular stabilizing factors prior to and following bypass surgery in patients with Moyamoya disease. Exp Ther Med. 2014;8(1):302\u20138.","journal-title":"Exp Ther Med"},{"issue":"2","key":"3769_CR14","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1177\/0271678X18818298","volume":"40","author":"A Marushima","year":"2020","unstructured":"Marushima A, Nieminen M, Kremenetskaia I, Gianni-Barrera R, Woitzik J, von Degenfeld G, et al. Balanced single-vector co-delivery of VEGF\/PDGF-BB improves functional collateralization in chronic cerebral ischemia. J Cereb Blood Flow Metab. 2020;40(2):404\u201319.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"5","key":"3769_CR15","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.ajhg.2009.04.007","volume":"84","author":"DC Guo","year":"2009","unstructured":"Guo DC, Papke CL, Tran-Fadulu V, Regalado ES, Avidan N, Johnson RJ, et al. Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease. Am J Hum Genet. 2009;84(5):617\u201327.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"3769_CR16","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/cge.12739","volume":"90","author":"S Wallace","year":"2016","unstructured":"Wallace S, Guo DC, Regalado E, Mellor-Crummey L, Bamshad M, Nickerson DA, et al. Disrupted nitric oxide signaling due to GUCY1A3 mutations increases risk for Moyamoya disease, achalasia and hypertension. Clin Genet. 2016;90(4):351\u201360.","journal-title":"Clin Genet"},{"issue":"3","key":"3769_CR17","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/cge.14650","volume":"107","author":"M Venema","year":"2025","unstructured":"Venema M, Albuainain F, Schot R, Roozenbeek B, Sleutels F, van Ham T, et al. BRCC3 -associated syndromic Moyamoya angiopathy diagnosed through clinical RNA sequencing. Clin Genet. 2025;107(3):341\u20137.","journal-title":"Clin Genet"},{"issue":"9","key":"3769_CR18","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1177\/1747493016662039","volume":"11","author":"OY Bang","year":"2016","unstructured":"Bang OY, Chung JW, Kim SJ, Oh MJ, Kim SY, Cho YH, et al. Caveolin-1, Ring finger protein 213, and endothelial function in Moyamoya disease. Int J Stroke. 2016;11(9):999\u20131008.","journal-title":"Int J Stroke"},{"key":"3769_CR19","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.8841","volume":"8","author":"Y Yang","year":"2020","unstructured":"Yang Y, Wang J, Liang Q, Wang Y, Chen X, Zhang Q, et al. PHACTR1 is associated with disease progression in Chinese Moyamoya disease. PeerJ. 2020;8:e8841.","journal-title":"PeerJ"},{"issue":"12","key":"3769_CR20","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1007\/s00701-010-0711-9","volume":"152","author":"C Roder","year":"2010","unstructured":"Roder C, Peters V, Kasuya H, Nishizawa T, Takehara Y, Berg D, et al. Polymorphisms in TGFB1 and PDGFRB are associated with Moyamoya disease in European patients. Acta Neurochir. 2010;152(12):2153\u201360.","journal-title":"Acta Neurochir"},{"issue":"2","key":"3769_CR21","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.gene.2013.05.083","volume":"526","author":"X Wang","year":"2013","unstructured":"Wang X, Zhang Z, Liu W, Xiong Y, Sun W, Huang X, et al. Impacts and interactions of PDGFRB, MMP-3, TIMP-2, and RNF213 polymorphisms on the risk of Moyamoya disease in Han Chinese human subjects. Gene. 2013;526(2):437\u201342.","journal-title":"Gene"},{"key":"3769_CR22","doi-asserted-by":"publisher","first-page":"1252681","DOI":"10.3389\/fcimb.2023.1252681","volume":"13","author":"X Yu","year":"2023","unstructured":"Yu X, Ge P, Zhai Y, Liu W, Zhang Q, Ye X, et al. Gut microbiota in adults with Moyamoya disease: characteristics and biomarker identification. Front Cell Infect Microbiol. 2023;13:1252681.","journal-title":"Front Cell Infect Microbiol"},{"issue":"10","key":"3769_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0164759","volume":"11","author":"H Kobayashi","year":"2016","unstructured":"Kobayashi H, Brozman M, Kyselov\u00e1 K, et al. RNF213 rare variants in Slovakian and Czech Moyamoya disease patients. PLoS ONE. 2016;11(10):e0164759.","journal-title":"PLoS ONE"},{"issue":"4","key":"3769_CR24","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3171\/2020.8.PEDS20391","volume":"27","author":"C Tschoe","year":"2021","unstructured":"Tschoe C, Kim TE, Fargen KM, Wolfe SQ. Cerebral arteriopathy in ACTA2 mutations: a spectrum of disease highlighted by a case of variable penetrance in two siblings. J Neurosurg Pediatr. 2021;27(4):446\u201351.","journal-title":"J Neurosurg Pediatr"},{"issue":"11","key":"3769_CR25","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.3174\/ajnr.A5823","volume":"39","author":"F D'Arco","year":"2018","unstructured":"D\u2019Arco F, Alves CA, Raybaud C, Chong WKK, Ishak GE, Ramji S, et al. Expanding the distinctive neuroimaging phenotype of ACTA2 mutations. AJNR Am J Neuroradiol. 2018;39(11):2126\u201331.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"3769_CR26","doi-asserted-by":"publisher","first-page":"6105","DOI":"10.1038\/s41467-025-61042-3","volume":"16","author":"A Kaw","year":"2025","unstructured":"Kaw A, Majumder S, Esparza Pinelo JE, Wu T, Starosolski Z, Zhou Z, et al. Immature Acta 2(R179C\/+) smooth muscle cells cause Moyamoya-like cerebrovascular lesions in mice prevented by boosting OXPHOS. Nat Commun. 2025;16(1):6105.","journal-title":"Nat Commun"},{"issue":"3","key":"3769_CR27","doi-asserted-by":"publisher","DOI":"10.3171\/2021.6.FOCUS21284","volume":"51","author":"MS Rallo","year":"2021","unstructured":"Rallo MS, Akel O, Gurram A, Sun H. Experimental animal models for moyamoya disease and treatment: a pathogenesis-oriented scoping review. Neurosurg Focus. 2021;51(3):E5.","journal-title":"Neurosurg Focus"},{"issue":"4","key":"3769_CR28","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.3171\/2016.2.JNS152173","volume":"126","author":"Q Zhang","year":"2017","unstructured":"Zhang Q, Liu Y, Zhang D, Wang R, Zhang Y, Wang S, et al. Rnf213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance. J Neurosurg. 2017;126(4):1106\u201313.","journal-title":"J Neurosurg"},{"issue":"3","key":"3769_CR29","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ajhg.2014.01.018","volume":"94","author":"D Herv\u00e9","year":"2014","unstructured":"Herv\u00e9 D, Philippi A, Belbouab R, Zerah M, Chabrier S, Collardeau-Frachon S, et al. Loss of \u03b11\u03b21 soluble guanylate cyclase, the major nitric oxide receptor, leads to Moyamoya and achalasia. Am J Hum Genet. 2014;94(3):385\u201394.","journal-title":"Am J Hum Genet"},{"key":"3769_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.687088","volume":"12","author":"Y Mineharu","year":"2021","unstructured":"Mineharu Y, Miyamoto S. Rnf213 and GUCY1A3 in Moyamoya disease: key regulators of metabolism, inflammation, and vascular stability. Front Neurol. 2021;12:687088.","journal-title":"Front Neurol"},{"issue":"7","key":"3769_CR31","doi-asserted-by":"publisher","first-page":"8248","DOI":"10.1007\/s12035-025-04763-2","volume":"62","author":"M Luo","year":"2025","unstructured":"Luo M, Mo D, Li J, Liu L, Li X, Lin J, et al. The guanylate cyclase soluble subunit alpha-1 deficiency impairs angiogenesis in zebrafishes and mice: in vivo and in vitro studies. Mol Neurobiol. 2025;62(7):8248\u201360.","journal-title":"Mol Neurobiol"},{"key":"3769_CR32","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20191454","author":"S Liu","year":"2019","unstructured":"Liu S, Liu M, Li Q, Liu X, Wang Y, Mambiya M, et al. Association of single nucleotide polymorphisms of MTHFR, TCN2, RNF213 with susceptibility to hypertension and blood pressure. 2019. Biosci Rep. https:\/\/doi.org\/10.1042\/BSR20191454."},{"issue":"10","key":"3769_CR33","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1007\/s00381-014-2495-3","volume":"30","author":"YS Park","year":"2014","unstructured":"Park YS, Jeon YJ, Kim HS, Han IB, Choi JU, Kim DS, et al. <article-title update=\"added\">The roles of methylenetetrahydrofolate reductase 677C>T and 1298A>C polymorphisms in moyamoya disease patients. Childs Nerv Syst. 2014;30(10):1687\u201395.","journal-title":"Childs Nerv Syst"},{"key":"3769_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s12975-024-01324-y","author":"J Li","year":"2025","unstructured":"Li J, He Q, Liu C, Zeng C, Zheng Z, Zhang B, et al. Association between folate metabolism risk, collateral circulation, and hemorrhagic risk in Moyamoya disease. Transl Stroke Res. 2025. https:\/\/doi.org\/10.1007\/s12975-024-01324-y.","journal-title":"Transl Stroke Res"},{"issue":"4","key":"3769_CR35","doi-asserted-by":"publisher","first-page":"936","DOI":"10.3171\/2024.1.JNS232121","volume":"141","author":"G Gao","year":"2024","unstructured":"Gao G, Bao XY, Wang QN, Wang XP, Hao FB, Liu SM, et al. Association between polymorphism in the MTHFR gene and encephaloduroarteriosynangiosis-induced collateral circulation formation. J Neurosurg. 2024;141(4):936\u201344.","journal-title":"J Neurosurg"},{"issue":"4","key":"3769_CR36","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1177\/0883073807301934","volume":"22","author":"A Skardoutsou","year":"2007","unstructured":"Skardoutsou A, Voudris KA, Mastroyianni S, Vagiakou E, Magoufis G, Koukoutsakis P. Moya moya syndrome in a child with pyruvate kinase deficiency and combined prothrombotic factors. J Child Neurol. 2007;22(4):474\u20138.","journal-title":"J Child Neurol"},{"issue":"12","key":"3769_CR37","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1161\/01.STR.0000103745.03393.39","volume":"34","author":"K Kurnik","year":"2003","unstructured":"Kurnik K, Kosch A, Str\u00e4ter R, Schobess R, Heller C, Nowak-G\u00f6ttl U. Recurrent thromboembolism in infants and children suffering from symptomatic neonatal arterial stroke: a prospective follow-up study. Stroke. 2003;34(12):2887\u201392.","journal-title":"Stroke"},{"issue":"1","key":"3769_CR38","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1161\/STROKEAHA.117.017430","volume":"49","author":"L Duan","year":"2018","unstructured":"Duan L, Wei L, Tian Y, Zhang Z, Hu P, Wei Q, et al. Novel susceptibility loci for Moyamoya disease revealed by a genome-wide association study. Stroke. 2018;49(1):11\u20138.","journal-title":"Stroke"},{"issue":"6","key":"3769_CR39","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.ajhg.2011.04.017","volume":"88","author":"S Miskinyte","year":"2011","unstructured":"Miskinyte S, Butler MG, Herv\u00e9 D, Sarret C, Nicolino M, Petralia JD, et al. Loss of BRCC3 deubiquitinating enzyme leads to abnormal angiogenesis and is associated with syndromic Moyamoya. Am J Hum Genet. 2011;88(6):718\u201328.","journal-title":"Am J Hum Genet"},{"issue":"25","key":"3769_CR40","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1182\/blood-2014-02-553685","volume":"123","author":"S Janczar","year":"2014","unstructured":"Janczar S, Fogtman A, Koblowska M, Baranska D, Pastorczak A, Wegner O, et al. Novel severe hemophilia A and Moyamoya (SHAM) syndrome caused by Xq28 deletions encompassing F8 and BRCC3 genes. Blood. 2014;123(25):4002\u20134.","journal-title":"Blood"},{"issue":"2","key":"3769_CR41","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1159\/000524482","volume":"14","author":"E Tzeravini","year":"2022","unstructured":"Tzeravini E, Samara S, Kouramba A, Vakrinos G, Efthimiou A, Tzetis M, et al. Severe hemophilia A and Moyamoya syndrome in a 19-year-old boy caused by Xq28 microdeletion. Case Rep Neurol. 2022;14(2):261\u20137.","journal-title":"Case Rep Neurol"},{"issue":"3","key":"3769_CR42","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/ng.1081","volume":"44","author":"C Bellenguez","year":"2012","unstructured":"Bellenguez C, Bevan S, Gschwendtner A, Spencer CCA, Burgess AI, Pirinen M, et al. Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet. 2012;44(3):328\u201333.","journal-title":"Nat Genet"},{"issue":"1","key":"3769_CR43","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcae381","volume":"7","author":"C Han","year":"2025","unstructured":"Han C, Richerson WT, Garza M, Rodeghier M, Mishra M, Davis LT, et al. Cerebrovascular reactivity and response times describe recent ischaemic symptomatology in patients with Moyamoya. Brain Commun. 2025;7(1):fcae381.","journal-title":"Brain Commun"},{"issue":"6","key":"3769_CR44","doi-asserted-by":"publisher","first-page":"558","DOI":"10.3340\/jkns.2009.46.6.558","volume":"46","author":"SH Hong","year":"2009","unstructured":"Hong SH, Wang KC, Kim SK, Cho BK, Park MH. Association of HLA-DR and -DQ genes with familial Moyamoya disease in Koreans. J Korean Neurosurg Soc. 2009;46(6):558\u201363.","journal-title":"J Korean Neurosurg Soc"},{"issue":"8","key":"3769_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0220858","volume":"14","author":"R Tashiro","year":"2019","unstructured":"Tashiro R, Niizuma K, Khor SS, Tokunaga K, Fujimura M, Sakata H, et al. Identification of HLA-DRB1*04:10 allele as risk allele for Japanese moyamoya disease and its association with autoimmune thyroid disease: a case-control study. PLoS ONE. 2019;14(8):e0220858.","journal-title":"PLoS ONE"},{"issue":"3","key":"3769_CR46","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000592","volume":"7","author":"J Wan","year":"2021","unstructured":"Wan J, Ling W, Zhengshan Z, Xianbo Z, Lian D, Kai W. Association of HLA-DQA2 and HLA-B with Moyamoya disease in the Chinese han population. Neurol Genet. 2021;7(3):e592.","journal-title":"Neurol Genet"},{"issue":"3","key":"3769_CR47","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00701-011-1261-5","volume":"154","author":"M Kraemer","year":"2012","unstructured":"Kraemer M, Horn PA, Roder C, Khan N, Diehl RR, Berlit P, et al. Analysis of human leucocyte antigen genes in Caucasian patients with idiopathic Moyamoya angiopathy. Acta Neurochir. 2012;154(3):445\u201354.","journal-title":"Acta Neurochir"},{"issue":"3","key":"3769_CR48","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.pediatrneurol.2012.11.009","volume":"48","author":"H Nzwalo","year":"2013","unstructured":"Nzwalo H, Santos V, Gradil C, Vieira JP, Mendon\u00e7a C. Caucasian familial moyamoya syndrome with rare multisystemic malformations. Pediatr Neurol. 2013;48(3):240\u20133.","journal-title":"Pediatr Neurol"},{"key":"3769_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104538","volume":"132","author":"GH Park","year":"2019","unstructured":"Park GH, Shin HS, Choi ES, Yoon BS, Choi MH, Lee SJ, et al. Cranial burr hole with erythropoietin administration induces reverse arteriogenesis from the enriched extracranium. Neurobiol Dis. 2019;132:104538.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"3769_CR50","doi-asserted-by":"publisher","first-page":"10732","DOI":"10.1038\/s41598-023-37665-1","volume":"13","author":"S He","year":"2023","unstructured":"He S, Hao X, Liu Z, Wang Y, Zhang J, Wang X, et al. Association between DIAPH1 variant and posterior circulation involvement with moyamoya disease. Sci Rep. 2023;13(1):10732.","journal-title":"Sci Rep"},{"issue":"8","key":"3769_CR51","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1001\/jamaneurol.2021.1681","volume":"78","author":"AJ Kundishora","year":"2021","unstructured":"Kundishora AJ, Peters ST, Pinard A, Duran D, Panchagnula S, Barak T, et al. DIAPH1 variants in non-East Asian patients with sporadic moyamoya disease. JAMA Neurol. 2021;78(8):993\u20131003.","journal-title":"JAMA Neurol"},{"issue":"4","key":"3769_CR52","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3892\/etm.2025.12824","volume":"29","author":"Y Wang","year":"2025","unstructured":"Wang Y, Su Y, Zhang J, Zhou Z, Zhao Y, He S, et al. Characterization of moyamoya disease molecular subtypes through disulfidptosis-related genes and immune landscape analysis. Exp Ther Med. 2025;29(4):74.","journal-title":"Exp Ther Med"},{"issue":"2","key":"3769_CR53","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1007\/s12035-024-04423-x","volume":"62","author":"J Li","year":"2025","unstructured":"Li J, He Q, Zheng Z, Liu C, Zhang B, Mou S, et al. Comprehensive analysis and in vitro verification of endothelial-mesenchymal transition-related genes in moyamoya disease. Mol Neurobiol. 2025;62(2):2515\u201329.","journal-title":"Mol Neurobiol"},{"key":"3769_CR54","doi-asserted-by":"publisher","first-page":"1101612","DOI":"10.3389\/fgene.2023.1101612","volume":"14","author":"L Cao","year":"2023","unstructured":"Cao L, Ai Y, Dong Y, Li D, Wang H, Sun K, et al. Bioinformatics analysis reveals the landscape of immune cell infiltration and novel immune-related biomarkers in moyamoya disease. Front Genet. 2023;14:1101612.","journal-title":"Front Genet"},{"issue":"1","key":"3769_CR55","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13023-022-02238-4","volume":"17","author":"F Jin","year":"2022","unstructured":"Jin F, Duan C. Identification of immune-infiltrated hub genes as potential biomarkers of moyamoya disease by bioinformatics analysis. Orphanet J Rare Dis. 2022;17(1):80.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"3769_CR56","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1186\/s13023-025-03945-4","volume":"20","author":"Z Zhou","year":"2025","unstructured":"Zhou Z, Niu H, Xu S, Zhang J, Liu Y, Lei C, et al. Angiogenesis-related genes and immune microenvironment in moyamoya disease: a transcriptomic and functional analysis. Orphanet J Rare Dis. 2025;20(1):385.","journal-title":"Orphanet J Rare Dis"},{"key":"3769_CR57","doi-asserted-by":"publisher","first-page":"1417329","DOI":"10.3389\/fgene.2024.1417329","volume":"15","author":"Z Han","year":"2024","unstructured":"Han Z, Zhang J, Su Y, Zhou Z, Wang Y, Xu S, et al. Identification of oxidative phosphorylation-related genes in moyamoya disease by combining bulk RNA-sequencing analysis and machine learning. Front Genet. 2024;15:1417329.","journal-title":"Front Genet"},{"issue":"6","key":"3769_CR58","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202401445R","volume":"39","author":"J Zhou","year":"2025","unstructured":"Zhou J, Lei Y, Zhang S, Qin R, Liu Y, Yi D. Identification of the potential role of S1PR1 in adult Moyamoya disease based on multiple bioinformatics analysis and experimental verification. FASEB J. 2025;39(6):e70461.","journal-title":"FASEB J"},{"key":"3769_CR59","doi-asserted-by":"publisher","first-page":"4442","DOI":"10.1038\/srep04442","volume":"4","author":"D Morito","year":"2014","unstructured":"Morito D, Nishikawa K, Hoseki J, Kitamura A, Kotani Y, Kiso K, et al. Moyamoya disease-associated protein mysterin\/RNF213 is a novel AAA+ ATPase, which dynamically changes its oligomeric state. Sci Rep. 2014;4:4442.","journal-title":"Sci Rep"},{"issue":"5","key":"3769_CR60","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2176\/nmc.52.299","volume":"52","author":"W Liu","year":"2012","unstructured":"Liu W, Hitomi T, Kobayashi H, Harada KH, Koizumi A. Distribution of Moyamoya disease susceptibility polymorphism p.R4810K in RNF213 in East and Southeast Asian populations. Neurol Med Chir (Tokyo). 2012;52(5):299\u2013303.","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"7","key":"3769_CR61","doi-asserted-by":"publisher","first-page":"e678","DOI":"10.1212\/WNL.0000000000008901","volume":"94","author":"Y Wang","year":"2020","unstructured":"Wang Y, Zhang Z, Wei L, Zhang Q, Zou Z, Yang L, et al. Predictive role of heterozygous p.R4810K of RNF213 in the phenotype of Chinese Moyamoya disease. Neurology. 2020;94(7):e678\u201386.","journal-title":"Neurology"},{"issue":"5","key":"3769_CR62","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3171\/2015.4.JNS142900","volume":"124","author":"EH Kim","year":"2016","unstructured":"Kim EH, Yum MS, Ra YS, Park JB, Ahn JS, Kim GH, et al. Importance of RNF213 polymorphism on clinical features and long-term outcome in Moyamoya disease. J Neurosurg. 2016;124(5):1221\u20137.","journal-title":"J Neurosurg"},{"key":"3769_CR63","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.brainres.2014.01.011","volume":"1552","author":"S Sonobe","year":"2014","unstructured":"Sonobe S, Fujimura M, Niizuma K, Nishijima Y, Ito A, Shimizu H, et al. Temporal profile of the vascular anatomy evaluated by 9.4-T magnetic resonance angiography and histopathological analysis in mice lacking RNF213: a susceptibility gene for Moyamoya disease. Brain Res. 2014;1552:64\u201371.","journal-title":"Brain Res"},{"issue":"1","key":"3769_CR64","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.bbrc.2013.07.004","volume":"438","author":"T Hitomi","year":"2013","unstructured":"Hitomi T, Habu T, Kobayashi H, Okuda H, Harada KH, Osafune K, et al. Downregulation of Securin by the variant RNF213 R4810K (rs112735431, G>A) reduces angiogenic activity of induced pluripotent stem cell-derived vascular endothelial cells from Moyamoya patients. Biochem Biophys Res Commun. 2013;438(1):13\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"3769_CR65","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002146","author":"H Kobayashi","year":"2015","unstructured":"Kobayashi H, Matsuda Y, Hitomi T, Okuda H, Shioi H, Matsuda T, et al. Biochemical and functional characterization of RNF213 (Mysterin) R4810K, a susceptibility mutation of Moyamoya disease, in angiogenesis in vitro and in vivo. J Am Heart Assoc. 2015. https:\/\/doi.org\/10.1161\/JAHA.115.002146.","journal-title":"J Am Heart Assoc"},{"key":"3769_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.843927","volume":"13","author":"Y Luo","year":"2022","unstructured":"Luo Y, Cao Z, Wu S, Sun X. Ring finger protein 213 in Moyamoya disease with pulmonary arterial hypertension: a mini-review. Front Neurol. 2022;13:843927.","journal-title":"Front Neurol"},{"issue":"4","key":"3769_CR67","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1161\/STROKEAHA.120.032691","volume":"53","author":"V Roy","year":"2022","unstructured":"Roy V, Ross JP, P\u00e9pin R, Cortez Ghio S, Brodeur A, Touzel Desch\u00eanes L, et al. Moyamoya disease susceptibility gene RNF213 regulates endothelial barrier function. Stroke. 2022;53(4):1263\u201375.","journal-title":"Stroke"},{"key":"3769_CR68","doi-asserted-by":"publisher","DOI":"10.3390\/cells12010078","author":"V Roy","year":"2022","unstructured":"Roy V, Brodeur A, Touzel Desch\u00eanes L, Dupr\u00e9 N, Gros-Louis F. Rnf213 loss-of-function promotes angiogenesis of cerebral microvascular endothelial cells in a cellular state dependent manner. Cells. 2022. https:\/\/doi.org\/10.3390\/cells12010078.","journal-title":"Cells"},{"issue":"12","key":"3769_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105305","volume":"29","author":"K Tokairin","year":"2020","unstructured":"Tokairin K, Hamauchi S, Ito M, Kazumata K, Sugiyama T, Nakayama N, et al. Vascular smooth muscle cell derived from IPS cell of Moyamoya disease - comparative characterization with endothelial cell transcriptome. J Stroke Cerebrovasc Dis. 2020;29(12):105305.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"3","key":"3769_CR70","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1083\/jcb.201712120","volume":"218","author":"M Sugihara","year":"2019","unstructured":"Sugihara M, Morito D, Ainuki S, Hirano Y, Ogino K, Kitamura A, et al. The AAA+ ATPase\/ubiquitin ligase mysterin stabilizes cytoplasmic lipid droplets. J Cell Biol. 2019;218(3):949\u201360.","journal-title":"J Cell Biol"},{"issue":"3","key":"3769_CR71","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.bbrc.2020.02.024","volume":"525","author":"M Takeda","year":"2020","unstructured":"Takeda M, Tezuka T, Kim M, Choi J, Oichi Y, Kobayashi H, et al. Moyamoya disease patient mutations in the RING domain of RNF213 reduce its ubiquitin ligase activity and enhance NF\u03baB activation and apoptosis in an AAA+ domain-dependent manner. Biochem Biophys Res Commun. 2020;525(3):668\u201374.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7861","key":"3769_CR72","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41586-021-03566-4","volume":"594","author":"EG Otten","year":"2021","unstructured":"Otten EG, Werner E, Crespillo-Casado A, Boyle KB, Dharamdasani V, Pathe C, et al. Ubiquitylation of lipopolysaccharide by RNF213 during bacterial infection. Nature. 2021;594(7861):111\u20136.","journal-title":"Nature"},{"issue":"1","key":"3769_CR73","doi-asserted-by":"publisher","first-page":"5772","DOI":"10.1038\/s41467-021-26061-w","volume":"12","author":"F Thery","year":"2021","unstructured":"Thery F, Martina L, Asselman C, Zhang Y, Vessely M, Repo H, et al. Ring finger protein 213 assembles into a sensor for ISGylated proteins with antimicrobial activity. Nat Commun. 2021;12(1):5772.","journal-title":"Nat Commun"},{"issue":"11","key":"3769_CR74","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/jhg.2009.91","volume":"54","author":"K Shimojima","year":"2009","unstructured":"Shimojima K, Yamamoto T. ACTA2 is not a major disease-causing gene for Moyamoya disease. J Hum Genet. 2009;54(11):687\u20138.","journal-title":"J Hum Genet"},{"issue":"7","key":"3769_CR75","doi-asserted-by":"publisher","DOI":"10.1111\/ijs.12074","volume":"8","author":"FY Hu","year":"2013","unstructured":"Hu FY, Zheng HB, Xu YM, Jiang Y, Zhou D. ACTA2 is not a major genetic risk gene for Chinese patients with Moyamoya disease. Int J Stroke. 2013;8(7):E43.","journal-title":"Int J Stroke"},{"issue":"2","key":"3769_CR76","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ejpn.2010.09.002","volume":"15","author":"C Roder","year":"2011","unstructured":"Roder C, Peters V, Kasuya H, Nishizawa T, Wakita S, Berg D, et al. Analysis of ACTA2 in European Moyamoya disease patients. Eur J Paediatr Neurol. 2011;15(2):117\u201322.","journal-title":"Eur J Paediatr Neurol"},{"issue":"Pt 8","key":"3769_CR77","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1093\/brain\/aws172","volume":"135","author":"P Munot","year":"2012","unstructured":"Munot P, Saunders DE, Milewicz DM, Regalado ES, Ostergaard JR, Braun KP, et al. A novel distinctive cerebrovascular phenotype is associated with heterozygous Arg179 ACTA2 mutations. Brain J Neurol. 2012;135(Pt 8):2506\u201314.","journal-title":"Brain J Neurol"},{"key":"3769_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114459","volume":"186","author":"I Sharina","year":"2021","unstructured":"Sharina I, Lezgyieva K, Krutsenko Y, Martin E. Higher susceptibility to heme oxidation and lower protein stability of the rare \u03b1(1)C517Y\u03b2(1) sGC variant associated with Moyamoya syndrome. Biochem Pharmacol. 2021;186:114459.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"3769_CR79","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40246-023-00471-x","volume":"17","author":"S Guey","year":"2023","unstructured":"Guey S, Herv\u00e9 D, Kossorotoff M, Ha G, Aloui C, Bergametti F, et al. Biallelic variants in NOS3 and GUCY1A3, the two major genes of the nitric oxide pathway, cause Moyamoya cerebral angiopathy. Hum Genomics. 2023;17(1):24.","journal-title":"Hum Genomics"},{"issue":"1","key":"3769_CR80","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ejmg.2015.12.004","volume":"59","author":"S Janczar","year":"2016","unstructured":"Janczar S, Kosinska J, Ploski R, Pastorczak A, Wegner O, Zalewska-Szewczyk B, et al. Haemophilia A and cardiovascular morbidity in a female SHAM syndrome carrier due to skewed X chromosome inactivation. Eur J Med Genet. 2016;59(1):43\u20137.","journal-title":"Eur J Med Genet"},{"issue":"1","key":"3769_CR81","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/jhg.2008.5","volume":"54","author":"T Shiina","year":"2009","unstructured":"Shiina T, Hosomichi K, Inoko H, Kulski JK. The HLA genomic loci map: expression, interaction, diversity and disease. J Hum Genet. 2009;54(1):15\u201339.","journal-title":"J Hum Genet"},{"issue":"1","key":"3769_CR82","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0198-8859(02)00706-1","volume":"64","author":"CR M\u00fcller","year":"2003","unstructured":"M\u00fcller CR, Ehninger G, Goldmann SF. Gene and haplotype frequencies for the loci hLA-A, hLA-B, and hLA-DR based on over 13,000 german blood donors. Hum Immunol. 2003;64(1):137\u201351.","journal-title":"Hum Immunol"},{"issue":"6532","key":"3769_CR83","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/375577a0","volume":"375","author":"D Mukhopadhyay","year":"1995","unstructured":"Mukhopadhyay D, Tsiokas L, Zhou XM, Foster D, Brugge JS, Sukhatme VP. Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature. 1995;375(6532):577\u201381.","journal-title":"Nature"},{"issue":"34","key":"3769_CR84","doi-asserted-by":"publisher","first-page":"19761","DOI":"10.1074\/jbc.270.34.19761","volume":"270","author":"E Ikeda","year":"1995","unstructured":"Ikeda E, Achen MG, Breier G, Risau W. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J Biol Chem. 1995;270(34):19761\u20136.","journal-title":"J Biol Chem"},{"issue":"43","key":"3769_CR85","doi-asserted-by":"publisher","first-page":"26988","DOI":"10.1016\/S0021-9258(18)47116-5","volume":"269","author":"J Waltenberger","year":"1994","unstructured":"Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin CH. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem. 1994;269(43):26988\u201395.","journal-title":"J Biol Chem"},{"issue":"1","key":"3769_CR86","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12975-021-00940-2","volume":"13","author":"R Mertens","year":"2022","unstructured":"Mertens R, Graupera M, Gerhardt H, Bersano A, Tournier-Lasserve E, Mensah MA, et al. The genetic basis of Moyamoya disease. Transl Stroke Res. 2022;13(1):25\u201345.","journal-title":"Transl Stroke Res"},{"issue":"4","key":"3769_CR87","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3171\/2024.1.JNS221977","volume":"141","author":"AD Kappel","year":"2024","unstructured":"Kappel AD, Feroze AH, Torio E, Sukumaran M, Du R. Management of Moyamoya disease: a review of current and future therapeutic strategies. J Neurosurg. 2024;141(4):975\u201382.","journal-title":"J Neurosurg"},{"key":"3769_CR88","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1750-1172-8-45","volume":"8","author":"TK Sigdel","year":"2013","unstructured":"Sigdel TK, Shoemaker LD, Chen R, Li L, Butte AJ, Sarwal MM, et al. Immune response profiling identifies autoantibodies specific to Moyamoya patients. Orphanet J Rare Dis. 2013;8:45.","journal-title":"Orphanet J Rare Dis"},{"issue":"12","key":"3769_CR89","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1161\/01.STR.24.12.1960","volume":"24","author":"J Masuda","year":"1993","unstructured":"Masuda J, Ogata J, Yutani C. Smooth muscle cell proliferation and localization of macrophages and T cells in the occlusive intracranial major arteries in Moyamoya disease. Stroke. 1993;24(12):1960\u20137.","journal-title":"Stroke"},{"issue":"10","key":"3769_CR90","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2176\/nmc.ra.2019-0059","volume":"59","author":"T Mikami","year":"2019","unstructured":"Mikami T, Suzuki H, Komatsu K, Mikuni N. Influence of inflammatory disease on the pathophysiology of Moyamoya disease and quasi-Moyamoya disease. Neurol Med Chir (Tokyo). 2019;59(10):361\u201370.","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"1","key":"3769_CR91","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1038\/s41598-017-03278-8","volume":"7","author":"L Weng","year":"2017","unstructured":"Weng L, Cao X, Han L, Zhao H, Qiu S, Yan Y, et al. Association of increased Treg and Th17 with pathogenesis of Moyamoya disease. Sci Rep. 2017;7(1):3071.","journal-title":"Sci Rep"},{"issue":"4","key":"3769_CR92","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3171\/jns.1998.89.4.0623","volume":"89","author":"M Hojo","year":"1998","unstructured":"Hojo M, Hoshimaru M, Miyamoto S, Taki W, Nagata I, Asahi M, et al. Role of transforming growth factor-beta1 in the pathogenesis of Moyamoya disease. J Neurosurg. 1998;89(4):623\u20139.","journal-title":"J Neurosurg"},{"issue":"10","key":"3769_CR93","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.ejmg.2012.05.002","volume":"55","author":"C Liu","year":"2012","unstructured":"Liu C, Roder C, Schulte C, Kasuya H, Akagawa H, Nishizawa T, et al. Analysis of TGFB1 in European and Japanese Moyamoya disease patients. Eur J Med Genet. 2012;55(10):531\u20134.","journal-title":"Eur J Med Genet"},{"issue":"8","key":"3769_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2025.108351","volume":"34","author":"X Wu","year":"2025","unstructured":"Wu X, Huang R, Su S, Li X, Lin X, Wang P, et al. Association of peripheral blood inflammatory biomarkers and poor clinical outcomes in adult stroke patients with Moyamoya disease. J Stroke Cerebrovasc Dis. 2025;34(8):108351.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"2","key":"3769_CR95","doi-asserted-by":"publisher","first-page":"2269368","DOI":"10.1080\/07853890.2023.2269368","volume":"55","author":"W Liu","year":"2023","unstructured":"Liu W, Liu C, Yu X, Zhai Y, He Q, Li J, et al. Association between systemic immune-inflammatory markers and the risk of Moyamoya disease: a case-control study. Ann Med. 2023;55(2):2269368.","journal-title":"Ann Med"},{"issue":"4","key":"3769_CR96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036386","volume":"7","author":"R Lin","year":"2012","unstructured":"Lin R, Xie Z, Zhang J, Xu H, Su H, Tan X, et al. Clinical and immunopathological features of Moyamoya disease. PLoS ONE. 2012;7(4):e36386.","journal-title":"PLoS ONE"},{"issue":"9","key":"3769_CR97","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0221811","volume":"14","author":"X Peng","year":"2019","unstructured":"Peng X, Zhang Z, Ye D, Xing P, Zou Z, Lei H, et al. Gene dysregulation in peripheral blood of moyamoya disease and comparison with other vascular disorders. PLoS ONE. 2019;14(9):e0221811.","journal-title":"PLoS ONE"},{"issue":"1","key":"3769_CR98","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1161\/STROKEAHA.109.562264","volume":"41","author":"SJ Kim","year":"2010","unstructured":"Kim SJ, Heo KG, Shin HY, Bang OY, Kim GM, Chung CS, et al. Association of thyroid autoantibodies with Moyamoya-type cerebrovascular disease: a prospective study. Stroke. 2010;41(1):173\u20136.","journal-title":"Stroke"},{"issue":"4","key":"3769_CR99","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1161\/STROKEAHA.110.608471","volume":"42","author":"H Li","year":"2011","unstructured":"Li H, Zhang ZS, Dong ZN, Ma MJ, Yang WZ, Han C, et al. Increased thyroid function and elevated thyroid autoantibodies in pediatric patients with Moyamoya disease: a case-control study. Stroke. 2011;42(4):1138\u20139.","journal-title":"Stroke"},{"issue":"12","key":"3769_CR100","doi-asserted-by":"publisher","first-page":"e244","DOI":"10.1161\/01.STR.0000100479.63243.48","volume":"34","author":"K Ogawa","year":"2003","unstructured":"Ogawa K, Nagahiro S, Arakaki R, Ishimaru N, Kobayashi M, Hayashi Y. Anti-alpha-fodrin autoantibodies in Moyamoya disease. Stroke. 2003;34(12):e244\u20136.","journal-title":"Stroke"},{"issue":"8","key":"3769_CR101","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1161\/01.STR.32.8.1786","volume":"32","author":"M Bonduel","year":"2001","unstructured":"Bonduel M, Hepner M, Sciuccati G, Torres AF, Tenembaum S. Prothrombotic disorders in children with Moyamoya syndrome. Stroke. 2001;32(8):1786\u201392.","journal-title":"Stroke"},{"issue":"1","key":"3769_CR102","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11011-020-00616-0","volume":"36","author":"W Han","year":"2021","unstructured":"Han W, Qiao Y, Zhang H, Geng C, Zhu X, Liao D, et al. Circulating sortilin levels are associated with inflammation in patients with Moyamoya disease. Metab Brain Dis. 2021;36(1):103\u20139.","journal-title":"Metab Brain Dis"},{"key":"3769_CR103","doi-asserted-by":"publisher","first-page":"5847478","DOI":"10.1155\/2020\/5847478","volume":"2020","author":"W Han","year":"2020","unstructured":"Han W, Jin F, Zhang H, Yang M, Cui C, Wang C, et al. Association of brain-gut peptides with inflammatory cytokines in Moyamoya disease. Mediators Inflamm. 2020;2020:5847478.","journal-title":"Mediators Inflamm"},{"issue":"6","key":"3769_CR104","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1136\/jnnp.2009.191817","volume":"81","author":"HS Kang","year":"2010","unstructured":"Kang HS, Kim JH, Phi JH, Kim YY, Kim JE, Wang KC, et al. Plasma matrix metalloproteinases, cytokines and angiogenic factors in Moyamoya disease. J Neurol Neurosurg Psychiatry. 2010;81(6):673\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"3769_CR105","doi-asserted-by":"publisher","first-page":"5605","DOI":"10.1111\/jcmm.15220","volume":"24","author":"X Fan","year":"2020","unstructured":"Fan X, He L, Dai Q, He J, Chen X, Dai X, et al. Interleukin-1\u03b2 augments the angiogenesis of endothelial progenitor cells in an NF-\u03baB\/CXCR7-dependent manner. J Cell Mol Med. 2020;24(10):5605\u201314.","journal-title":"J Cell Mol Med"},{"issue":"7","key":"3769_CR106","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41419-019-1716-9","volume":"10","author":"AQ Chen","year":"2019","unstructured":"Chen AQ, Fang Z, Chen XL, Yang S, Zhou YF, Mao L, et al. Microglia-derived TNF-\u03b1 mediates endothelial necroptosis aggravating blood brain-barrier disruption after ischemic stroke. Cell Death Dis. 2019;10(7):487.","journal-title":"Cell Death Dis"},{"key":"3769_CR107","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.brainres.2017.11.013","volume":"1679","author":"M Fujimura","year":"2018","unstructured":"Fujimura M, Fujimura T, Kakizaki A, Sato-Maeda M, Niizuma K, Tomata Y, et al. Increased serum production of soluble CD163 and CXCL5 in patients with Moyamoya disease: involvement of intrinsic immune reaction in its pathogenesis. Brain Res. 2018;1679:39\u201344.","journal-title":"Brain Res"},{"key":"3769_CR108","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.jconrel.2023.08.025","volume":"361","author":"W Peng","year":"2023","unstructured":"Peng W, Xie Y, Liu Y, Xu J, Yuan F, Li C, et al. Targeted delivery of CD163(+) macrophage-derived small extracellular vesicles via RGD peptides promote vascular regeneration and stabilization after spinal cord injury. J Control Release. 2023;361:750\u201365.","journal-title":"J Control Release"},{"key":"3769_CR109","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222413410","author":"M Dei Cas","year":"2021","unstructured":"Dei Cas M, Carrozzini T, Pollaci G, Potenza A, Nava S, Canavero I, et al. Plasma lipid profiling contributes to untangle the complexity of Moyamoya arteriopathy. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms222413410.","journal-title":"Int J Mol Sci"},{"key":"3769_CR110","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.721118","volume":"12","author":"J Lu","year":"2021","unstructured":"Lu J, Wang J, Lin Z, Shi G, Wang R, Zhao Y, et al. MMP-9 as a biomarker for predicting hemorrhagic strokes in Moyamoya disease. Front Neurol. 2021;12:721118.","journal-title":"Front Neurol"},{"issue":"5","key":"3769_CR111","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.surneu.2008.10.009","volume":"72","author":"M Fujimura","year":"2009","unstructured":"Fujimura M, Watanabe M, Narisawa A, Shimizu H, Tominaga T. Increased expression of serum Matrix Metalloproteinase-9 in patients with Moyamoya disease. Surg Neurol. 2009;72(5):476\u201380.","journal-title":"Surg Neurol"},{"issue":"11","key":"3769_CR112","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1111\/j.1468-1331.2011.03393.x","volume":"18","author":"G Ni","year":"2011","unstructured":"Ni G, Liu W, Huang X, Zhu S, Yue X, Chen Z, et al. Increased levels of circulating SDF-1\u03b1 and CD34+ CXCR4+ cells in patients with Moyamoya disease. Eur J Neurol. 2011;18(11):1304\u20139.","journal-title":"Eur J Neurol"},{"issue":"3","key":"3769_CR113","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2021.10456","volume":"22","author":"C Wang","year":"2021","unstructured":"Wang C, Sun C, Zhao Y, Song H, Li Z, Jin F, et al. RNF213 gene silencing upregulates transforming growth factor \u03b21 expression in bone marrow-derived mesenchymal stem cells and is involved in the onset of Moyamoya disease. Exp Ther Med. 2021;22(3):1024.","journal-title":"Exp Ther Med"},{"issue":"11","key":"3769_CR114","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1007\/s00381-011-1504-z","volume":"27","author":"YS Park","year":"2011","unstructured":"Park YS, Min KT, Kim TG, Lee YH, Cheong HJ, Yeom IS, et al. Age-specific eNOS polymorphisms in Moyamoya disease. Childs Nerv Syst. 2011;27(11):1919\u201326.","journal-title":"Childs Nerv Syst"},{"issue":"9","key":"3769_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104830","volume":"29","author":"JH Silver","year":"2020","unstructured":"Silver JH, Jaffe RA, L\u00f3pez JR. Plasma nitrite as an indicator of cerebral ischemia during extracranial\/intracranial bypass surgery in Moyamoya patients. J Stroke Cerebrovasc Dis. 2020;29(9):104830.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"3769_CR116","doi-asserted-by":"publisher","DOI":"10.3390\/cells14110775","author":"J Choi","year":"2025","unstructured":"Choi J, Inoue R, Masuo Y, Shimizu Y, Sonomura K, Kim M, et al. Rnf213 acts as a molecular switch for Cav-1 ubiquitination and phosphorylation in human cells. Cells. 2025. https:\/\/doi.org\/10.3390\/cells14110775.","journal-title":"Cells"},{"issue":"11","key":"3769_CR117","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1161\/STROKEAHA.118.021888","volume":"49","author":"JW Chung","year":"2018","unstructured":"Chung JW, Kim DH, Oh MJ, Cho YH, Kim EH, Moon GJ, et al. Cav-1 (Caveolin-1) and arterial remodeling in adult Moyamoya disease. Stroke. 2018;49(11):2597\u2013604.","journal-title":"Stroke"},{"issue":"6","key":"3769_CR118","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1002\/acn3.52076","volume":"11","author":"G Gorla","year":"2024","unstructured":"Gorla G, Potenza A, Carrozzini T, Pollaci G, Acerbi F, Vetrano IG, et al. Angiopoietin-2 associates with poor prognosis in Moyamoya angiopathy. Ann Clin Transl Neurol. 2024;11(6):1590\u2013603.","journal-title":"Ann Clin Transl Neurol"},{"issue":"6","key":"3769_CR119","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.3171\/2023.4.JNS23479","volume":"139","author":"T Chen","year":"2023","unstructured":"Chen T, Wei W, Zhang J, Yu J, Xu S, Wu D, et al. Assessment of plasma soluble Tie-2 level to distinguish Moyamoya disease from atherosclerotic cerebrovascular disease and predict postoperative neovascularization. J Neurosurg. 2023;139(6):1705\u201314.","journal-title":"J Neurosurg"},{"key":"3769_CR120","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.899470","volume":"13","author":"Y Chen","year":"2022","unstructured":"Chen Y, Tang M, Li H, Liu H, Wang J, Huang J. TGF\u03b21 as a predictive biomarker for collateral formation within ischemic Moyamoya disease. Front Neurol. 2022;13:899470.","journal-title":"Front Neurol"},{"issue":"2","key":"3769_CR121","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70054","volume":"6","author":"S He","year":"2025","unstructured":"He S, Zhou Z, Cheng MY, Hao X, Chiang T, Wang Y, et al. Advances in Moyamoya disease: pathogenesis, diagnosis, and therapeutic interventions. MedComm. 2025;6(2):e70054.","journal-title":"MedComm"},{"key":"3769_CR122","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021233","author":"G Gorla","year":"2023","unstructured":"Gorla G, Carrozzini T, Pollaci G, Potenza A, Nava S, Acerbi F, et al. Increase of circulating endothelial progenitor cells and released angiogenic factors in children with Moyamoya arteriopathy. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24021233.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3769_CR123","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s12975-020-00834-9","volume":"12","author":"QN Wang","year":"2021","unstructured":"Wang QN, Zou ZX, Wang XP, Zhang Q, Zhao YQ, Duan L, et al. Endothelial progenitor cells induce angiogenesis: a potential mechanism underlying neovascularization in encephaloduroarteriosynangiosis. Transl Stroke Res. 2021;12(2):357\u201365.","journal-title":"Transl Stroke Res"},{"key":"3769_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2023.111184","volume":"169","author":"Y Guo","year":"2023","unstructured":"Guo Y, Dou W, Wang X, Wang X, Mao H, Chen K. Can combined high-resolution vessel wall imaging and multiple post-labeling delay 3D pseudo-continuous arterial spin labeling differentiate Moyamoya disease from atherosclerotic Moyamoya syndrome? Eur J Radiol. 2023;169:111184.","journal-title":"Eur J Radiol"},{"key":"3769_CR125","doi-asserted-by":"publisher","DOI":"10.1177\/0271678X251358979","author":"MY Zhao","year":"2025","unstructured":"Zhao MY, Alexander S, Lopez CA, Zhang H, Morton G, Armindo RD, et al. Characterizing pre- and post-operative cerebral blood flow and transit time in pediatric Moyamoya patients using multi-delay ASL and DSC MRI. J Cereb Blood Flow Metab. 2025. https:\/\/doi.org\/10.1177\/0271678X251358979.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"5","key":"3769_CR126","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1159\/000087935","volume":"20","author":"K Houkin","year":"2005","unstructured":"Houkin K, Nakayama N, Kuroda S, Nonaka T, Shonai T, Yoshimoto T. Novel magnetic resonance angiography stage grading for Moyamoya disease. Cerebrovasc Dis. 2005;20(5):347\u201354.","journal-title":"Cerebrovasc Dis"},{"issue":"1145","key":"3769_CR127","doi-asserted-by":"publisher","first-page":"20230114","DOI":"10.1259\/bjr.20230114","volume":"96","author":"S Das","year":"2023","unstructured":"Das S, Mossa-Basha M, Dey M, Hazra A, Pandit A, Das G, et al. High-resolution vessel wall magnetic resonance imaging in intracranial vasculopathies: an experience from eastern India. Br J Radiol. 2023;96(1145):20230114.","journal-title":"Br J Radiol"},{"issue":"10","key":"3769_CR128","doi-asserted-by":"publisher","first-page":"6918","DOI":"10.1007\/s00330-023-09951-z","volume":"33","author":"S Liu","year":"2023","unstructured":"Liu S, Lu M, Gao X, Wen C, Sun B, Liu Y, et al. The diagnostic performance of high-resolution magnetic resonance-vessel wall imaging in differentiating atherosclerosis-associated Moyamoya vasculopathy from Moyamoya disease. Eur Radiol. 2023;33(10):6918\u201326.","journal-title":"Eur Radiol"},{"key":"3769_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2025.112238","volume":"190","author":"F Ouyang","year":"2025","unstructured":"Ouyang F, Wu Q, Chen J, Liu J, Luo Z, Yan M, et al. Association of intravascular enhancement sign on 3D T1- weighted TSE sequences with cerebral perfusion and infarction events in Moyamoya disease. Eur J Radiol. 2025;190:112238.","journal-title":"Eur J Radiol"},{"issue":"7","key":"3769_CR130","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s11604-025-01758-w","volume":"43","author":"M Gomyo","year":"2025","unstructured":"Gomyo M, Tsuchiya K, Yokoyama K. Noninvasive dynamic vascular imaging: arterial spin labeling-based noncontrast magnetic resonance digital subtraction angiography for cerebral disease diagnoses. Jpn J Radiol. 2025;43(7):1049\u201365.","journal-title":"Jpn J Radiol"},{"issue":"11","key":"3769_CR131","doi-asserted-by":"publisher","first-page":"4871","DOI":"10.1007\/s00330-018-5462-7","volume":"28","author":"O Togao","year":"2018","unstructured":"Togao O, Hiwatashi A, Obara M, Yamashita K, Momosaka D, Nishimura A, et al. 4D ASL-based MR angiography for visualization of distal arteries and leptomeningeal collateral vessels in Moyamoya disease: a comparison of techniques. Eur Radiol. 2018;28(11):4871\u201381.","journal-title":"Eur Radiol"},{"issue":"6","key":"3769_CR132","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.3171\/2015.5.JNS15767","volume":"124","author":"X Deng","year":"2016","unstructured":"Deng X, Zhang Z, Zhang Y, Zhang D, Wang R, Ye X, et al. Comparison of 7.0- and 3.0-T MRI and MRA in ischemic-type Moyamoya disease: preliminary experience. J Neurosurg. 2016;124(6):1716\u201325.","journal-title":"J Neurosurg"},{"key":"3769_CR133","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci14121190","author":"P Haas","year":"2024","unstructured":"Haas P, Hauser TK, Wiggenhauser LM, Zerweck L, Tatagiba M, Khan N, et al. Coincidence of concentric vessel-wall contrast enhancement in Moyamoya disease and acute postoperative ischemic stroke during revascularization procedures. Brain Sci. 2024. https:\/\/doi.org\/10.3390\/brainsci14121190.","journal-title":"Brain Sci"},{"issue":"1","key":"3769_CR134","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41598-020-80036-3","volume":"11","author":"A Huang","year":"2021","unstructured":"Huang A, Lee CW, Liu HM. Time to peak and full width at half maximum in MR perfusion: valuable indicators for monitoring Moyamoya patients after revascularization. Sci Rep. 2021;11(1):479.","journal-title":"Sci Rep"},{"issue":"1","key":"3769_CR135","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s10143-025-03660-5","volume":"48","author":"O Alwakaa","year":"2025","unstructured":"Alwakaa O, Mensah E, Ramirez-Velandia F, Enriquez-Marulanda A, Muram S, Bukhari SS, et al. The orbital grading system yields higher precision than the Matsushima grading system in assessing angiographic outcomes after EDAS for Moyamoya disease: an interrater reliability analysis. Neurosurg Rev. 2025;48(1):513.","journal-title":"Neurosurg Rev"},{"issue":"3","key":"3769_CR136","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70245","volume":"31","author":"S Huang","year":"2025","unstructured":"Huang S, Pei S, Han Y, Xu J, Wang L, Fu H, et al. The role of TCD in assessing postoperative collateral development and long-term clinical outcome in Moyamoya disease. CNS Neurosci Ther. 2025;31(3):e70245.","journal-title":"CNS Neurosci Ther"},{"issue":"14","key":"3769_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e34432","volume":"10","author":"W Li","year":"2024","unstructured":"Li W, Zhao X, Fu J, Cheng L. Identification of lysosome-related hub genes as potential biomarkers and immune infiltrations of Moyamoya disease by multiple bioinformatics methods and machine-learning strategies. Heliyon. 2024;10(14):e34432.","journal-title":"Heliyon"},{"key":"3769_CR138","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering12060577","author":"C Tan","year":"2025","unstructured":"Tan C, Wang X, Zhou Z, Liu Y, He S, Zhao Y. A machine learning-based diagnostic nomogram for Moyamoya disease: the validation of hypoxia-immune gene signatures. Bioengineering. 2025. https:\/\/doi.org\/10.3390\/bioengineering12060577.","journal-title":"Bioengineering"},{"key":"3769_CR139","doi-asserted-by":"publisher","first-page":"1581338","DOI":"10.3389\/fneur.2025.1581338","volume":"16","author":"H Huang","year":"2025","unstructured":"Huang H, Zheng N, Feng L, Shao S. Research progress of artificial intelligence in Moyamoya disease. Front Neurol. 2025;16:1581338.","journal-title":"Front Neurol"},{"issue":"5","key":"3769_CR140","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s00234-025-03605-1","volume":"67","author":"G Zhu","year":"2025","unstructured":"Zhu G, Jiang B, Chen H, Heit JJ, Etter M, Hishaw GA, et al. Using generative adversarial deep learning networks to synthesize cerebrovascular reactivity imaging from pre-acetazolamide arterial spin labeling in Moyamoya disease. Neuroradiology. 2025;67(5):1251\u201362.","journal-title":"Neuroradiology"},{"issue":"11","key":"3769_CR141","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000213617","volume":"104","author":"Q Duan","year":"2025","unstructured":"Duan Q, Lyu J, Liu Z, Hao F, Li R, Liu S, et al. Noninvasive assessment of the risk features of hemorrhage in Moyamoya disease using 7T MRI. Neurology. 2025;104(11):e213617.","journal-title":"Neurology"},{"issue":"2","key":"3769_CR142","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1148\/radiol.2021203568","volume":"299","author":"P Liu","year":"2021","unstructured":"Liu P, Liu G, Pinho MC, Lin Z, Thomas BP, Rundle M, et al. Cerebrovascular reactivity mapping using resting-state BOLD functional MRI in healthy adults and patients with Moyamoya disease. Radiology. 2021;299(2):419\u201325.","journal-title":"Radiology"},{"issue":"4","key":"3769_CR143","doi-asserted-by":"publisher","first-page":"696","DOI":"10.3174\/ajnr.A5068","volume":"38","author":"S Hara","year":"2017","unstructured":"Hara S, Tanaka Y, Ueda Y, Hayashi S, Inaji M, Ishiwata K, et al. Noninvasive evaluation of cbf and perfusion delay of Moyamoya disease using arterial spin-labeling MRI with multiple postlabeling delays: comparison with (15)O-Gas PET and DSC-MRI. AJNR Am J Neuroradiol. 2017;38(4):696\u2013702.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"3769_CR144","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/jmri.26773","volume":"51","author":"Y Ishii","year":"2020","unstructured":"Ishii Y, Thamm T, Guo J, Khalighi MM, Wardak M, Holley D, et al. Simultaneous phase-contrast MRI and PET for noninvasive quantification of cerebral blood flow and reactivity in healthy subjects and patients with cerebrovascular disease. J Magn Reson Imaging. 2020;51(1):183\u201394.","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"3769_CR145","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1136\/svn-2024-003336","volume":"10","author":"W Li","year":"2025","unstructured":"Li W, Zhao M, Liu X, Wang P, Zhu H, Zhang Q, et al. Understanding external carotid artery collateralisation after cerebral revascularisation in Moyamoya disease: insights from quantitative analysis. Stroke Vasc Neurol. 2025;10(3):371\u20138.","journal-title":"Stroke Vasc Neurol"},{"issue":"11","key":"3769_CR146","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.778","volume":"5","author":"MG Shi","year":"2024","unstructured":"Shi MG, Feng XM, Zhi HY, Hou L, Feng DF. Machine learning-based radiomics in neurodegenerative and cerebrovascular disease. MedComm. 2024;5(11):e778.","journal-title":"MedComm"},{"issue":"1","key":"3769_CR147","doi-asserted-by":"publisher","first-page":"24655","DOI":"10.1038\/s41598-025-08796-4","volume":"15","author":"EJ Koh","year":"2025","unstructured":"Koh EJ, Choi SA, Moon YJ, Lee H, Phi JH, Kim SK. Plasma extracellular vesicle-associated miR-512-3p modulates angiogenesis in pediatric Moyamoya disease by targeting ARHGEF3. Sci Rep. 2025;15(1):24655.","journal-title":"Sci Rep"},{"issue":"5","key":"3769_CR148","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e26748","volume":"10","author":"J Liu","year":"2024","unstructured":"Liu J, Chen C, Qin X, Wang J, Zhang B, Jin F. Plasma-derived exosomes contributes to endothelial-to-mesenchymal transition in Moyamoya disease. Heliyon. 2024;10(5):e26748.","journal-title":"Heliyon"},{"issue":"11","key":"3769_CR149","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e32022","volume":"10","author":"M Wang","year":"2024","unstructured":"Wang M, Zhang B, Jin F, Li G, Cui C, Feng S. Exosomal MicroRNAs: Biomarkers of Moyamoya disease and involvement in vascular cytoskeleton reconstruction. Heliyon. 2024;10(11):e32022.","journal-title":"Heliyon"},{"issue":"1","key":"3769_CR150","doi-asserted-by":"publisher","DOI":"10.1186\/s41016-024-00358-3","volume":"10","author":"P Ge","year":"2024","unstructured":"Ge P, Yin Z, Tao C, Zeng C, Yu X, Lei S, et al. Multiomics and blood-based biomarkers of Moyamoya disease: protocol of Moyamoya Omics Atlas (MOYAOMICS). Chin Neurosurg J. 2024;10(1):5.","journal-title":"Chin Neurosurg J"},{"key":"3769_CR151","doi-asserted-by":"publisher","DOI":"10.3390\/cells11233792","author":"Y Liu","year":"2022","unstructured":"Liu Y, Huang Y, Zhang X, Ma X, He X, Gan C, et al. CircZXDC promotes vascular smooth muscle cell transdifferentiation via regulating miRNA-125a-3p\/ABCC6 in Moyamoya disease. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11233792.","journal-title":"Cells"},{"issue":"3","key":"3769_CR152","doi-asserted-by":"publisher","first-page":"150","DOI":"10.4103\/bc.bc_38_19","volume":"5","author":"S Corey","year":"2019","unstructured":"Corey S, Luo Y. Circular RNAs and neutrophils: Key factors in tackling asymptomatic Moyamoya disease. Brain Circ. 2019;5(3):150\u20135.","journal-title":"Brain Circ"},{"issue":"3","key":"3769_CR153","doi-asserted-by":"publisher","first-page":"709","DOI":"10.3171\/2022.5.JNS22579","volume":"138","author":"T Mamiya","year":"2023","unstructured":"Mamiya T, Kanamori F, Yokoyama K, Ota A, Karnan S, Uda K, et al. Long noncoding RNA profile of the intracranial artery in patients with Moyamoya disease. J Neurosurg. 2023;138(3):709\u201316.","journal-title":"J Neurosurg"},{"key":"3769_CR154","doi-asserted-by":"publisher","DOI":"10.1038\/srep42421","volume":"7","author":"W Wang","year":"2017","unstructured":"Wang W, Gao F, Zhao Z, Wang H, Zhang L, Zhang D, et al. Integrated analysis of LncRNA-mRNA co-expression profiles in patients with Moyamoya disease. Sci Rep. 2017;7:42421.","journal-title":"Sci Rep"},{"issue":"1","key":"3769_CR155","doi-asserted-by":"publisher","DOI":"10.1186\/s13062-024-00522-w","volume":"19","author":"D Guo","year":"2024","unstructured":"Guo D, Dong Y, Li H, Li H, Yang B. Proteomics and digital subtraction angiography approaches reveal CDH18 as a potential target for therapy of Moyamoya disease. Biol Direct. 2024;19(1):76.","journal-title":"Biol Direct"},{"issue":"10","key":"3769_CR156","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1161\/STROKEAHA.120.032297","volume":"52","author":"X Wang","year":"2021","unstructured":"Wang X, Han C, Jia Y, Wang J, Ge W, Duan L. Proteomic profiling of exosomes from hemorrhagic Moyamoya disease and dysfunction of mitochondria in endothelial cells. Stroke. 2021;52(10):3351\u201361.","journal-title":"Stroke"},{"key":"3769_CR157","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241311194","author":"T Carrozzini","year":"2023","unstructured":"Carrozzini T, Pollaci G, Gorla G, Potenza A, Rifino N, Acerbi F, et al. Proteome profiling of the dura mater in patients with Moyamoya angiopathy. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241311194.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3769_CR158","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1097\/JS9.0000000000002092","volume":"111","author":"K He","year":"2025","unstructured":"He K, Wang X, Gu Y, Tong X, Qin X, Liao Y, et al. In-depth cerebrovascular lipidomics profiling for discovering novel biomarkers and mechanisms in Moyamoya and intracranial atherosclerotic disease. Int J Surg. 2025;111(1):1607\u201313.","journal-title":"Int J Surg"},{"issue":"11","key":"3769_CR159","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.1111\/cns.14254","volume":"29","author":"J Li","year":"2023","unstructured":"Li J, He Q, Liu C, Zeng C, Tao C, Zhai Y, et al. Integrated analysis of the association between methionine cycle and risk of Moyamoya disease. CNS Neurosci Ther. 2023;29(11):3212\u201327.","journal-title":"CNS Neurosci Ther"},{"key":"3769_CR160","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2024.117602","volume":"100","author":"R Tashiro","year":"2024","unstructured":"Tashiro R, Anzawa R, Inoue T, Mikagi A, Ozaki D, Tominaga K, et al. The prognostic values of plasma desmosines, crosslinking molecules of elastic fibers, in the disease progression of Moyamoya disease. Bioorg Med Chem. 2024;100:117602.","journal-title":"Bioorg Med Chem"},{"issue":"7","key":"3769_CR161","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1177\/0271678X231162184","volume":"43","author":"S He","year":"2023","unstructured":"He S, Liang J, Xue G, Wang Y, Zhao Y, Liu Z, et al. RNA profiling of sEV (small extracellular vesicles)\/exosomes reveals biomarkers and vascular endothelial dysplasia with Moyamoya disease. J Cereb Blood Flow Metab. 2023;43(7):1194\u2013205.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"12","key":"3769_CR162","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.3328","volume":"13","author":"Q Guo","year":"2023","unstructured":"Guo Q, Wang QN, Li J, Liu S, Wang X, Yu D, et al. Proteomic and metabolomic characterizations of Moyamoya disease patient sera. Brain Behav. 2023;13(12):e3328.","journal-title":"Brain Behav"},{"issue":"4","key":"3769_CR163","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3109\/08880018.2011.650838","volume":"29","author":"SS Meena","year":"2012","unstructured":"Meena SS, Ramkumar TV, Sharma S, Aneja S, Kumar A. Moyamoya syndrome associated with severe iron deficiency anemia in a young child. Pediatr Hematol Oncol. 2012;29(4):368\u201371.","journal-title":"Pediatr Hematol Oncol"},{"issue":"1","key":"3769_CR164","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00726-021-03100-w","volume":"54","author":"X Liu","year":"2022","unstructured":"Liu X, Jin F, Wang C, Zhao S, Han S, Jiang P, et al. Targeted metabolomics analysis of serum amino acid profiles in patients with Moyamoya disease. Amino Acids. 2022;54(1):137\u201346.","journal-title":"Amino Acids"},{"issue":"17","key":"3769_CR165","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000629","volume":"94","author":"JP Jeon","year":"2015","unstructured":"Jeon JP, Yun T, Jin X, Cho WS, Son YJ, Bang JS, et al. 1H-NMR-based metabolomic analysis of cerebrospinal fluid from adult bilateral Moyamoya disease: comparison with unilateral Moyamoya disease and atherosclerotic stenosis. Medicine. 2015;94(17):e629.","journal-title":"Medicine"},{"issue":"15","key":"3769_CR166","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.025676","volume":"11","author":"T Ok","year":"2022","unstructured":"Ok T, Jung YH, Kim J, Park SK, Park G, Lee S, et al. RNF213 R4810K variant in suspected unilateral Moyamoya disease predicts contralateral progression. J Am Heart Assoc. 2022;11(15):e025676.","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"3769_CR167","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s12975-021-00956-8","volume":"13","author":"D Ishigami","year":"2022","unstructured":"Ishigami D, Miyawaki S, Imai H, Shimizu M, Hongo H, Dofuku S, et al. RNF213 p.Arg4810Lys heterozygosity in Moyamoya disease indicates early onset and bilateral cerebrovascular events. Transl Stroke Res. 2022;13(3):410\u20139.","journal-title":"Transl Stroke Res"},{"key":"3769_CR168","doi-asserted-by":"crossref","unstructured":"Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis HLSRGfRoMfID. Guidelines for diagnosis and treatment of Moyamoya disease (spontaneous occlusion of the circle of Willis). Neurologia medico-chirurgica. 2012;52(5):245\u201366.","DOI":"10.2176\/nmc.52.245"},{"issue":"1-2","key":"3769_CR169","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1159\/000503250","volume":"48","author":"P Ge","year":"2019","unstructured":"Ge P, Ye X, Liu X, Deng X, Wang J, Wang R, et al. Association between p.R4810K variant and postoperative collateral formation in patients with Moyamoya disease. Cerebrovasc Dis. 2019;48(1\u20132):77\u201384.","journal-title":"Cerebrovasc Dis"},{"issue":"11","key":"3769_CR170","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1212\/WNL.0b013e318249f71f","volume":"78","author":"S Miyatake","year":"2012","unstructured":"Miyatake S, Miyake N, Touho H, Nishimura-Tadaki A, Kondo Y, Okada I, et al. Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of Moyamoya disease. Neurology. 2012;78(11):803\u201310.","journal-title":"Neurology"},{"key":"3769_CR171","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12030823","author":"W Liu","year":"2023","unstructured":"Liu W, Sun J, Shi Z, Huang Z, Yu L, Du H, et al. Circulating inflammatory cytokine associated with poor prognosis in Moyamoya disease: a prospective cohort study. J Clin Med. 2023. https:\/\/doi.org\/10.3390\/jcm12030823.","journal-title":"J Clin Med"},{"issue":"6","key":"3769_CR172","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1161\/STROKEAHA.120.029527","volume":"51","author":"X Wang","year":"2020","unstructured":"Wang X, Wang Y, Nie F, Li Q, Zhang K, Liu M, et al. Association of genetic variants with Moyamoya disease in 13 000 individuals: a meta-analysis. Stroke. 2020;51(6):1647\u201355.","journal-title":"Stroke"},{"issue":"1","key":"3769_CR173","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-025-03816-y","volume":"20","author":"Q Tang","year":"2025","unstructured":"Tang Q, Ma C, Li H, Xie J, Bian W, Lu Q, et al. Integrative molecular subtyping and diagnostic model construction for Moyamoya disease based on diverse programmed cell death gene patterns. Orphanet J Rare Dis. 2025;20(1):268.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"3769_CR174","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-025-03446-y","volume":"22","author":"Q Guo","year":"2025","unstructured":"Guo Q, Xie M, Wang X, Han C, Gao G, Wang QN, et al. Multi-omic serum analysis reveals ferroptosis pathways and diagnostic molecular signatures associated with Moyamoya diseases. J Neuroinflammation. 2025;22(1):123.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"3769_CR175","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-10003-3","volume":"15","author":"Z Han","year":"2025","unstructured":"Han Z, Yuan J, Zhou Z, Liu Y, Lei C, Ye X, et al. Machine learning identifies KRT8 dysregulation and endothelial remodeling in Moyamoya disease. Sci Rep. 2025;15(1):24171.","journal-title":"Sci Rep"},{"key":"3769_CR176","doi-asserted-by":"publisher","first-page":"1633487","DOI":"10.3389\/fpubh.2025.1633487","volume":"13","author":"Q Zhao","year":"2025","unstructured":"Zhao Q, Zhang C, Zhang W, Zhang S, Liu Q, Guo Y. Applications and challenges of biomarker-based predictive models in proactive health management. Front Public Health. 2025;13:1633487.","journal-title":"Front Public Health"},{"issue":"8","key":"3769_CR177","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202405580","volume":"12","author":"R Weng","year":"2025","unstructured":"Weng R, Xu Y, Gao X, Cao L, Su J, Yang H, et al. Non-invasive diagnosis of Moyamoya disease using serum metabolic fingerprints and machine learning. Adv Sci (Weinh). 2025;12(8):e2405580.","journal-title":"Adv Sci (Weinh)"},{"issue":"12","key":"3769_CR178","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1007\/s12031-022-02092-w","volume":"72","author":"Z Wang","year":"2022","unstructured":"Wang Z, Ji C, Han Q, Wang Z, Huang Y. Data-independent acquisition-based serum proteomic profiling of Adult Moyamoya disease patients reveals the potential pathogenesis of vascular changes. J Mol Neurosci MN. 2022;72(12):2473\u201385.","journal-title":"J Mol Neurosci MN"},{"key":"3769_CR179","volume":"77","author":"M Lu","year":"2024","unstructured":"Lu M, Zheng Y, Liu S, Zhang X, Lv J, Liu Y, et al. Deep learning model for automated diagnosis of Moyamoya disease based on magnetic resonance angiography. EClin Med. 2024;77:102888.","journal-title":"EClin Med"},{"key":"3769_CR180","doi-asserted-by":"publisher","DOI":"10.1007\/s11604-025-01806-5","author":"Y Ma","year":"2025","unstructured":"Ma Y, Nakajima S, Fushimi Y, Funaki T, Otani S, Takiya M, et al. Deep learning reconstruction for improved image quality of ultra-high-resolution brain CT angiography: application in Moyamoya disease. Jpn J Radiol. 2025. https:\/\/doi.org\/10.1007\/s11604-025-01806-5.","journal-title":"Jpn J Radiol"},{"issue":"5","key":"3769_CR181","doi-asserted-by":"publisher","first-page":"830","DOI":"10.4103\/1673-5374.297085","volume":"16","author":"Y Lei","year":"2021","unstructured":"Lei Y, Zhang X, Ni W, Yang H, Su JB, Xu B, et al. Recognition of Moyamoya disease and its hemorrhagic risk using deep learning algorithms: sourced from retrospective studies. Neural Regen Res. 2021;16(5):830\u20135.","journal-title":"Neural Regen Res"},{"issue":"3","key":"3769_CR182","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1161\/STROKEAHA.123.044026","volume":"55","author":"J Hong","year":"2024","unstructured":"Hong J, Yoon S, Shim KW, Park YR. Screening of Moyamoya Disease From Retinal Photographs: development and validation of deep learning algorithms. Stroke. 2024;55(3):715\u201324.","journal-title":"Stroke"},{"issue":"1","key":"3769_CR183","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s10143-024-02537-3","volume":"47","author":"LS Santana","year":"2024","unstructured":"Santana LS, Leite M, Yoshikawa MH, Santana LS, Larcipretti ALL, Gasparri LG, et al. Evaluation of deep learning algorithms in detecting Moyamoya disease: a systematic review and single-arm meta-analysis. Neurosurg Rev. 2024;47(1):300.","journal-title":"Neurosurg Rev"},{"issue":"Pt C","key":"3769_CR184","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2025.110780","volume":"196","author":"TAE Thornblad","year":"2025","unstructured":"Thornblad TAE, Ewals LJS, Nederend J, Luyer MDP, De With PHN, van der Sommen F. Clinical insights to improve medical deep learning design: A comprehensive review of methods and benefits. Comput Biol Med. 2025;196(Pt C):110780.","journal-title":"Comput Biol Med"},{"issue":"5","key":"3769_CR185","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1177\/17474930241297031","volume":"20","author":"N Rifino","year":"2025","unstructured":"Rifino N, Herv\u00e8 D, Acerbi F, Kuroda S, Lanzino G, Vajkoczy P, et al. Diagnosis and management of adult Moyamoya angiopathy: an overview of guideline recommendations and identification of future research directions. Int J Stroke. 2025;20(5):512\u201323.","journal-title":"Int J Stroke"},{"issue":"1","key":"3769_CR186","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s13244-024-01848-9","volume":"15","author":"Z Chen","year":"2024","unstructured":"Chen Z, Adegboro AA, Gu L, Li X. Constructing and exploring neuroimaging projects: a survey from clinical practice to scientific research. Insights Imaging. 2024;15(1):272.","journal-title":"Insights Imaging"},{"key":"3769_CR187","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-025-02252-9","author":"L Yu","year":"2025","unstructured":"Yu L, Feng R, Sun Y, Peng Y. Governance of cross-border genomic data sharing through a human rights approach. Nat Genet. 2025. https:\/\/doi.org\/10.1038\/s41588-025-02252-9.","journal-title":"Nat Genet"},{"issue":"1","key":"3769_CR188","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12910-022-00822-8","volume":"23","author":"AS Abdelhafiz","year":"2022","unstructured":"Abdelhafiz AS, Ahram M, Ibrahim ME, Elgamri A, Gamel E, Labib R, et al. Biobanks in the low- and middle-income countries of the Arab Middle East region: challenges, ethical issues, and governance arrangements-a qualitative study involving biobank managers. BMC Med Ethics. 2022;23(1):83.","journal-title":"BMC Med Ethics"},{"issue":"1","key":"3769_CR189","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1017\/S0963180120000614","volume":"30","author":"S Mahomed","year":"2021","unstructured":"Mahomed S. Human biobanking in developed and developing countries: an ethico-legal comparative analysis of the frameworks in the United Kingdom, Australia, Uganda, and South Africa. Camb Q Healthcare Ethics CQ Int J Healthcare Ethics Comm. 2021;30(1):146\u201360.","journal-title":"Camb Q Healthcare Ethics CQ Int J Healthcare Ethics Comm"},{"issue":"1","key":"3769_CR190","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s11926-025-01189-6","volume":"27","author":"MR Pellico","year":"2025","unstructured":"Pellico MR, Day J, Shah M, Yi BY, Saketkoo LA, Lood C, et al. Biorepositories for global rare disease research: a narrative review. Curr Rheumatol Rep. 2025;27(1):24.","journal-title":"Curr Rheumatol Rep"},{"key":"3769_CR191","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.nbt.2022.01.006","volume":"68","author":"V Ghini","year":"2022","unstructured":"Ghini V, Abuja PM, Polasek O, Kozera L, Laiho P, Anton G, et al. Impact of the pre-examination phase on multicenter metabolomic studies. New Biotechnol. 2022;68:37\u201347.","journal-title":"New Biotechnol"},{"issue":"1","key":"3769_CR192","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s13167-021-00234-5","volume":"12","author":"J Kinkorov\u00e1","year":"2021","unstructured":"Kinkorov\u00e1 J. Education for future biobankers - the state-of-the-art and outlook. EPMA J. 2021;12(1):15\u201325.","journal-title":"EPMA J"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03769-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03769-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03769-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T13:03:35Z","timestamp":1770123815000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-025-03769-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,3]]},"references-count":192,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3769"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03769-9","relation":{"references":[{"id-type":"doi","id":"10.1042\/BSR20191454","asserted-by":"subject"}]},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,3]]},"assertion":[{"value":"26 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not available.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"187"}}